PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
2.000
+0.045 (2.30%)
At close: Nov 14, 2025, 4:00 PM EST
1.990
-0.010 (-0.50%)
After-hours: Nov 14, 2025, 6:18 PM EST
PetMed Express Market Cap
PetMed Express has a market cap or net worth of $42 million as of November 14, 2025. Its market cap has decreased by -50.07% in one year.
Market Cap
42.00M
Enterprise Value
-12.67M
1-Year Change
-50.07%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since January 23, 2004, PetMed Express's market cap has decreased from $198.30M to $42.00M, a decrease of -78.82%. That is a compound annual growth rate of -6.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 41.10M | -58.73% |
| Dec 31, 2024 | 99.60M | -37.71% |
| Dec 29, 2023 | 159.90M | -57.13% |
| Dec 30, 2022 | 373.00M | -29.49% |
| Dec 31, 2021 | 529.00M | -18.60% |
| Dec 31, 2020 | 649.90M | 36.97% |
| Dec 31, 2019 | 474.50M | -1.33% |
| Dec 31, 2018 | 480.90M | -48.70% |
| Dec 29, 2017 | 937.50M | 97.99% |
| Dec 30, 2016 | 473.50M | 35.87% |
| Dec 31, 2015 | 348.50M | 19.68% |
| Dec 31, 2014 | 291.20M | -13.28% |
| Dec 31, 2013 | 335.80M | 51.19% |
| Dec 31, 2012 | 222.10M | 5.21% |
| Dec 30, 2011 | 211.10M | -47.98% |
| Dec 31, 2010 | 405.80M | 0.59% |
| Dec 31, 2009 | 403.40M | -2.77% |
| Dec 31, 2008 | 414.90M | 40.07% |
| Dec 31, 2007 | 296.20M | -8.35% |
| Dec 29, 2006 | 323.20M | -3.84% |
| Dec 30, 2005 | 336.10M | 88.61% |
| Dec 31, 2004 | 178.20M | -10.14% |
| Jan 23, 2004 | 198.30M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.19B |
| Johnson & Johnson | 466.99B |
| AbbVie | 397.96B |
| UnitedHealth Group | 296.62B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 225.74B |
| Abbott Laboratories | 220.84B |